Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,586,623
-
Total 13F shares
-
1,011,836
-
Share change
-
+270,873
-
Total reported value
-
$5,967,000
-
Price per share
-
$5.90
-
Number of holders
-
10
-
Value change
-
+$1,597,317
-
Number of buys
-
8
-
Number of sells
-
4
Institutional Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q1 2021
As of 31 Mar 2021,
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,011,836 shares.
The largest 10 holders included
AIGH Capital Management LLC, Roumell Asset Management, LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, Minot Wealth Management LLC, BlackRock Inc., PERRITT CAPITAL MANAGEMENT INC, WELLS FARGO & COMPANY/MN, CITIGROUP INC, and MORGAN STANLEY.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.